期刊文献+

复合维生素预防出生缺陷的效果评价

Evaluation of protective effect of multivitamin on birth defects
原文传递
导出
摘要 目的:系统评价妇女补充复合维生素对预防出生缺陷的效果。方法:计算机检索PubMed、Web of Science、EMBASE、中国生物医学文献数据库、万方数据库、中国知网中国期刊全文数据库,获取有关补充复合维生素预防出生缺陷的研究资料进行定量综合分析;运用STATA11进行异质性检验以及合并OR值和95%可信区间的计算。结果:对于神经管畸形和先天性心脏病,Meta分析结果显示,补充复合维生素对二者有预防保护作用,合并OR值和95%可信区间分别为0.33(0.18,0.59)和0.61(0.45,0.82);对于其他出生缺陷,还不能认为补充复合维生素对其有预防保护作用。结论:妇女围孕期补充复合维生素对于神经管畸形和先天性心脏病有预防保护作用,受纳入文献数量的限制,对于其他出生缺陷是否具有同样的预防保护作用还需要进一步加大样本予以证实。 Objective: To systematically evaluate the protective effect of multivitamin supplement on birth defects. Methods : The research data about preventing birth defects by supplementing multivitamin were obtained by searching PubMed, Web of Science, EMBASE, CBM, Wanfang database and CNKI using a computer, STATA11 software was used to conduct heterogeneity test and calculate pooled OR val- ue and 95% CI. Results: The results of Meta analysis showed that multivitamin supplement had protective effect on neural tube defects and congenital heart disease, the pooled OR value and 95% C1 were 0. 33 (0. 18, 0. 59) and 0. 61 (0. 45,0. 82), respectively; but it was not confirmed that multivitamin supplement had preventive and protective effect on the other birth defects. Conclusion: Multivitamin supplement during perieonceptional period has preventive and protective effect on neural tube defects and congenital heart disease, restricted to the num- ber of inclusion literatures, more samples are needed to confirm whether multivitamin supplement has the same preventive and protective effect on the other birth defects.
出处 《中国妇幼保健》 CAS 北大核心 2014年第14期2298-2300,共3页 Maternal and Child Health Care of China
基金 上海市公共卫生高端人才海外研修项目〔GWHW2012S10〕 上海市公共卫生优秀学科带头人培养计划〔GWDTR201205〕 上海市公共卫生重点学科建设项目-卫生经济〔12GWZX0601〕
关键词 妇女 复合维生素 出生缺陷 META分析 Woman Multivitamin Birth defect Meta analysis
  • 相关文献

参考文献25

  • 1曾宪涛,包翠萍,曹世义,刘菊英.Meta分析系列之三:随机对照试验的质量评价工具[J].中国循证心血管医学杂志,2012,4(3):183-185. 被引量:247
  • 2曾宪涛,刘慧,陈曦,冷卫东.Meta分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299. 被引量:991
  • 3Smithells RW,Sheppard S,Schorah CJ,et al. Possible pre-vention of neural - tube defects by periconceptional vitaminsupplementation[ J]. Lancet, 1980,1(8164) :339 -340.
  • 4Laurence KM, James N, Miller MH, et al. Double - blindrandomised controlled trial of folate treatment before concep-tion to prevent recurrence of neural - tube defects[ J]. BrMed J (Clin Res Ed),1981,282 (6275) : 1509 -1511.
  • 5Mills JL, Signore C. Neural tube defect rates before and afterfood fortification with folic acid[ J]. Birth Defects Res A ClinMol Teratol,2004, 70 (11) : 844 - 845.
  • 6Czeizel AE. Periconceptional folic acid containing multivitam insupplementation[ J]. Eur J Obstet Gynecol Reprod Biol,1998,78 (2) : 151 -161.
  • 7Botto LD,Mulinare J, Erickson JD. Occurrence of omphalo-cele in relation to maternal multivitamin use : a population -based study [J] . Pediatrics,2002,109 (5) : 904-908.
  • 8Botto LD, Olney RS, Erickson JD. Vitamin supplements and therisk for congenital anomalies other than neural tube defects[ J].Am J Med Genet C Semin Med Genet, 2(XM, 125(1) :12-21.
  • 9Werler MM,Hayes C,Louik C,et al. Multivitamin supple-mentation and risk of birth defects [ J]. Am J Epidemiol,1999,150 (7) : 675 -682.
  • 10Czeizel AE. Prevention of the first occurrence of neural - tubedefects by periconceptional vitamin supplementation[J]. NEngl J Med, 1992, 327 (26) : 1832 -1835.

二级参考文献26

  • 1Higgins JPT,Green S.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[EB/OL].The Cochrane Collaboration,2011[2012-03-30].http:∥www.cochrane-handbook.org.
  • 2Grimes DA,Schulz KF.An overview of clinical research:the lay of the land[J].Lancet,2002,359(9300):57-61.
  • 3Verhagen AP,de Vet HC,de Bie RA,et al.The Delphi list:a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus[J].J Clin Epidemiol,1998,51(12):1235-1241.
  • 4Centre for Evidence-Based Physiotherapy at The George Institute for Global Health.Physiotherapy Evidence Database(PEDro)[CP/OL].(1999-06-21)[2012-03-30].http://Available from http://www.pedro.org.au/english/downloads/pedro-scale.
  • 5Chalmers TC,Smith H Jr,Blackburn B,et al.A method for assessing the quality of a randomized control trial[J].Control Clin Trials,1981,2(1):31-49.
  • 6Critical Appraisal Skills Programme (CASP).RCT checklist_14.10.10[EP/OL].[2012-03-30].http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_RCT_Appraisal_Checklist_14oct10.pdf.
  • 7Jadad AR,Moore RA,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary[J]?Control Clin Trials,1996,17(1):1-12.
  • 8Schulz KF,Altman DG,Moher D,CONSORT Group.CONSORT 2010 statement:updated guidelines for reporting parallel group randomised trials[J].Int J Surg,2011,9(8):672-677.
  • 9Bian Z,Liu B,Moher D,et al.Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine:current situation and future development[J].Front Med,2011,5(2):171-177.
  • 10Moher D,Jadad AR,Nichol G,et al.Assessing the quality of randomized controlled trials:an annotated bibliography of scales and checklists[J].Control Clin Trials,1995,16(1):62-73.

共引文献1208

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部